Calator

HealthDay – MONDAY, June 29 (HealthDay News) — Treatment with interferon gamma-1b
(Ifn-g1b) does not improve survival in people with a fatal lung disease
called idiopathic pulmonary fibrosis, according to a study that was halted
early after no benefit to participants was found.

This entry was posted on Tuesday, June 30th, 2009 at 10:33 pm and is filed under Calator. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.